Demonstration of thiopurine methyltransferase activity in the erythrocytesof cats

Citation
Ap. Foster et al., Demonstration of thiopurine methyltransferase activity in the erythrocytesof cats, J VET INT M, 14(5), 2000, pp. 552-554
Citations number
19
Categorie Soggetti
Veterinary Medicine/Animal Health
Journal title
JOURNAL OF VETERINARY INTERNAL MEDICINE
ISSN journal
08916640 → ACNP
Volume
14
Issue
5
Year of publication
2000
Pages
552 - 554
Database
ISI
SICI code
0891-6640(200009/10)14:5<552:DOTMAI>2.0.ZU;2-6
Abstract
Azathioprine is a purine analogue used as an immunosuppressive and immunomo dulator agent in various mammals, including cats. Several adverse reactions have been reported and have limited the use of the drug in the cat. Advers e reactions to azathioprine in humans have been correlated with reduced act ivity of thiopurine methyltransferase (TPMT) in erythrocytes. The purpose o f this preliminary study was to determine if cats have TPMT activity in the ir erythrocytes and to compare the values obtained with the normal range fo r humans and the normal range for dogs in a preliminary report. Activity of the enzyme was measured in blood samples drawn from 41 cats. Blood also wa s taken from 5 dogs. The mean erythrocyte TPMT activity in the cats was 2.4 +/- 0.4 nmol (range, 1.2-3.9 nmol) per hour per milliliter of red blood ce lls (U/mL RBC) or 2-8 nmol per hour per gram of hemoglobin (U/g Hb). This r ange was far lower than the normal human range (8-15 U/mL RBC; 16-33 U/g Hb ) and was of monopolar distribution. This observation apparently precludes any diagnostic purpose in assaying erythrocyte TPMT in this species. Erythr ocyte TPMT activity in the 5 dogs ranged from 5.5 to 13.1 U/mL RBC (11-27 U /g Hb), which was comparable with normal and carrier ranges for humans, but proof of TPMT genetic polymorphism in either species will require genotypi ng studies.